CRISPR Therapeutics AG CRSP:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:44 PM EDT
65.64quote price arrow down-0.03 (-0.05%)
Volume
18,207
Close
65.67quote price arrow up+2.57 (+4.07%)
Volume
1,339,610
52 week range
42.51 - 110.01
Loading...
  • Open64.40
  • Day High66.21
  • Day Low64.39
  • Prev Close63.10
  • 52 Week High110.01
  • 52 Week High Date10/04/21
  • 52 Week Low42.51
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap5.123B
  • Shares Out78.01M
  • 10 Day Average Volume1.13M
  • Dividend-
  • Dividend Yield-
  • Beta1.85
  • YTD % Change-13.34

KEY STATS

  • Open64.40
  • Day High66.21
  • Day Low64.39
  • Prev Close63.10
  • 52 Week High110.01
  • 52 Week High Date10/04/21
  • 52 Week Low42.51
  • 52 Week Low Date05/12/22
  • Market Cap5.123B
  • Shares Out78.01M
  • 10 Day Average Volume1.13M
  • Dividend-
  • Dividend Yield-
  • Beta1.85
  • YTD % Change-13.34

RATIOS/PROFITABILITY

  • EPS (TTM)-8.23
  • P/E (TTM)-7.98
  • Fwd P/E (NTM)-7.14
  • EBITDA (TTM)-608.886M
  • ROE (TTM)-26.99%
  • Revenue (TTM)14.82M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-4,274.02%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date10/30/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CRISPR Therapeutics AG

 

Profile

MORE
CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined...
Rodger Novak M.D.
Chairman of the Board, President, Co-Founder
Samarth Kulkarni Ph.D.
Chief Executive Officer, Director
Lawrence Klein Ph.D.
Chief Operating Officer
Brendan Smith
Chief Financial Officer
James Kasinger J.D.
General Counsel, Secretary
Address
Baarerstrasse 14
Zug
6300
Switzerland

Top Peers

SYMBOLLASTCHG%CHG
ASND
Ascendis Pharma A/S
108.59+9.17+9.22%
NTLA
Intellia Therapeutics Inc
60.88+5.05+9.05%
CERE
Cerevel Therapeutics Holdings Inc
30.14+1.08+3.72%
ITCI
Intra-Cellular Therapies Inc
48.71+0.95+1.99%
GBT
Global Blood Therapeutics Inc
68.49+0.01+0.01%